SpectraCure AB
2OK
Company Profile
Business description
SpectraCure AB develops treatment planning and laser light dose management for cancer treatment. The Company has developed its software IDOSE, and medical laser devices for the treatment.
Contact
Magistratsvagen 10
Lund22643
SWET: +46 46162070
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
13
Stocks News & Analysis
stocks
Weight loss drugs not an existential threat to undervalued ASX share
A durable growth story despite GLP-1 headwinds.
stocks
Tesla: valuation is key consideration in merger talks with SpaceX
We see regulatory risk from both the US and Chinese governments.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,968.80 | 42.20 | 0.47% |
| CAC 40 | 7,906.39 | 59.07 | 0.75% |
| DAX 40 | 25,613.54 | 202.70 | 0.80% |
| Dow JONES (US) | 52,420.35 | 58.77 | 0.11% |
| FTSE 100 | 10,684.30 | 83.03 | -0.77% |
| HKSE | 23,041.32 | 170.49 | -0.73% |
| NASDAQ | 26,449.82 | 280.44 | 1.07% |
| Nikkei 225 | 63,268.37 | 1,078.72 | 1.73% |
| NZX 50 Index | 13,680.27 | 53.66 | -0.39% |
| S&P 500 | 7,722.33 | 45.56 | 0.59% |
| S&P/ASX 200 | 8,850.10 | 40.20 | 0.46% |
| SSE Composite Index | 3,648.30 | 49.22 | -1.33% |